You are here

Platelets Market to Witness Growth with Rising Demand for Advanced Therapies; Projected to Expand at a CAGR of 5.3% from 2025 to 2037

Research Nester has published a report titled "Platelets Market: Supply & Demand Analysis, Growth Forecasts & Statistics Report 2025-2037," which evaluates the major factors driving market expansion, including the increasing prevalence of hematologic disorders, rising demand for platelet transfusions in surgeries, and advancements in platelet storage and preservation technologies. The report segments the market by type, application, end user, highlighting the growing impact of platelet-rich plasma (PRP) therapies and regenerative medicine in healthcare. It provides a comprehensive assessment of key factors, challenges, and emerging opportunities influencing the future of the platelets market.
Request Report Sample@
https://www.researchnester.com/sample-request-7152
Advancements in Transfusion Medicine and Regenerative Therapies to Boost Market Growth
The platelets market is growing at a steady rate owing to the increasing number of patients suffering from blood disorders and the need for platelets in various medical procedures. Diseases like thrombocytopenia, hemato-oncology diseases, and disorders in the function of platelets have created a need for improved methods of platelet collection and preservation. The increased population of people undergoing surgeries and the increasing rate of accidents also boost market growth. Improvements in platelet storage and pathogen reduction technology are improving the availability of platelets and their safety. Also, awareness regarding blood donation and government policies to enhance the healthcare sector is propelling the market growth. With further advancements in regenerative medicine, the market is likely to expand with more products based on platelets.
Key Drivers and Challenges Impacting the Platelets Market
Growth Drivers:
• Growing prevalence of blood-related disorders, including thrombocytopenia and leukemia.
• Increasing demand for platelet transfusions in surgical and trauma cases.
• Expanding application of platelet-rich plasma (PRP) in regenerative medicine and aesthetics.
• Technological advancements in platelet storage and preservation to extend shelf life.
Challenges:
• Limited shelf life of platelets, leading to supply chain constraints.
• Shortage of voluntary blood and platelet donors in several regions.
• High costs associated with advanced platelet processing and storage technologies.
• Regulatory complexities regarding blood product safety and transfusion protocols.
The apheresis-derived platelets segment is expected to hold the largest market share of 54.0% by 2037 due to its safety and efficacy in transfusion medicine. The use of apheresis makes it possible to obtain platelets from a single donor, and it is less likely to cause immune reactions and infections as compared to whole-blood-derived platelets. The use of apheresis-derived platelets is on the rise because of higher yields and shelf life in comparison to whole blood-derived platelets, especially in patients requiring chemotherapy, organ transplant, and major surgery. Furthermore, apheresis technology has advanced in terms of collection systems where donors are able to donate through automated systems. The segment is also experiencing increased awareness of voluntary platelet donation programs, which are helping to replenish hospital and transfusion centers’ stocks. Due to the need for dependable and high-quality platelet supplies that are in demand in healthcare facilities, apheresis-derived platelets are anticipated to increase.
North America is expected to dominate the global platelets market with a share of 32.0% during the forecast period owing to its strong healthcare structure and effective blood banking services. The increasing rate of hematological disorders and the growing population of people are some of the factors encouraging the use of platelet transfusion in the United States. Other factors that are helping the growth of the market include government campaigns for blood donations and investments in the technologies used in the preservation of platelets. The existence of sound health care policies in Canada and rising research activities in the field of transfusion medicine are the major factors driving demand for enhanced platelet storage and collection techniques. It is believed that the region’s emphasis on the production of pathogen-reduced platelets and improving platelet shelf-life will increase the availability of platelets for transfusion. Also, partnerships between healthcare institutions and research organizations are establishing new platelet-based therapies, which is highly beneficial for North America.
The market is highly fragmented, and the major players are involved in R & D, collaborations, and technology advancements in platelet collection and storage. Some of the key players in the market include Aggredyne Inc., American National Red Cross, Arthrex, Inc., Asahi Kasei Medical Co., Ltd., Cellphire, Inc., Eurobio Scientific UK, Terumo Corporation, Thermo Fisher Scientific Inc., Sysmex Corporation, and Zimmer Biomet. These firms are focusing on the development of new and innovative technologies for the storage of platelets, pathogen reduction systems, and automated blood separation equipment to enhance the quality and availability of the platelets. Collaborations with healthcare organizations and governmental bodies are developing market reach and research activities related to transfusion medicine. With the increasing demand for innovative platelet-based solutions, companies are aiming to diversify their offerings and optimize their logistics to enhance their market presence.
Access our detailed report at:
https://www.researchnester.com/reports/platelets-market/7152
Research Nester Analytics is a leading service provider for strategic market research and consulting. We provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make informed decisions regarding future marketing strategy, expansion, and investments. We believe every business can expand its horizon with the right guidance at the right time. Our out-of-the-box thinking helps clients navigate future uncertainties and market dynamics.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919